The coordinated actions of TIM-3 on cancer and myeloid cells in the regulation of tumorigenicity and clinical prognosis in clear cell renal cell carcinomas

Cancer Immunology Research

Volumn 3, Issue 9, 2015, Pages 999-1007

  Komohara, Yoshihiro ^a   Morita, Tomoko ^b   Annan, Dorcas A ^b   Horlad, Hasita ^a   Ohnishi, Koji ^a   Yamada, Sohsuke ^c   Nakayama, Toshiyuki ^c   Kitada, Shohei ^c   Suzu, Shinya ^d   Kinoshita, Ichiro ^e   Dosaka Akita, Hirotoshi ^e   Akashi, Koichi ^f   Takeya, Motohiro ^a   Jinushi, Masahisa ^b,g  

^a KUMAMOTO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TIM 3; RAPAMYCIN; SUNITINIB; UNCLASSIFIED DRUG; VIRUS RECEPTOR; ANTINEOPLASTIC AGENT; HAVCR2 PROTEIN, HUMAN; INDOLE DERIVATIVE; MEMBRANE PROTEIN; PYRROLE DERIVATIVE; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; AGED; ANIMAL; APOPTOSIS; CANCER TRANSPLANTATION; CELL TRANSFORMATION; COCULTURE; DRUG EFFECTS; KAPLAN MEIER METHOD; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SCID MOUSE; TUMOR CELL CULTURE; XENOGRAFT;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; CELL TRANSFORMATION, NEOPLASTIC; COCULTURE TECHNIQUES; DRUG RESISTANCE, NEOPLASM; FEMALE; HETEROGRAFTS; HUMANS; INDOLES; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROGNOSIS; PYRROLES; SIROLIMUS; TUMOR CELLS, CULTURED;

EID: 84961994266     PISSN: 23266066     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0156     Document Type: Article

References (30)

1. Patel AR, Prasad SM, Shih YC, Eggener SE. The association of the human development index with global kidney cancer incidence and mortality. J Urol 2012;187:1978-83.
2. Russell CM, Espiritu PN, Kassouf W, Schwaab T, Buethe DD, Dhilon J, et al. Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort. J Urol 2014;192:350-6.
3. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009;27:3584-90.
4. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536-41.
5. Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol 2011;32:345-9.
6. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005;6:1245-52.
7. Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012;13:832-42.
8. Jinushi M. Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment. Oncoimmunology 2012;1:1632-4.
9. Wiener Z, Kohalmi B, Pocza P, Jeager J, Tolgyesi G, Toth S, et al. TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J Invest Dermatol 2007;127:906-14.
10. Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X, et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2012;56:1342-51.
11. Zhuang X, Zhang X, Xia X, Zhang C, Liang X, Gao L, et al. Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC. Am J Clin Pathol 2012;137:978-85.
12. Kitada S, Yamada S, Kuma A, Ouchi S, Tasaki T, Nabeshima A, et al. Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. Br J Cancer 2013;109:472-81.
13. Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008;216:15-24.
14. Fourcade J, Sun Z, Benallaoua M, Guillaume P, Luescher IF, Sander C, et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction inmelanoma patients. J Exp Med 2010;207:2175-86.
15. Sakurai T, Misawa R, Tanaka-Douzono M, Hagesita H, Nomaguchi K, Kuhara T, et al. Effect of coadministration of M-CSF and IFN-a on NK1.1+ cells in mice. J Interferon Cytokine Res 2002;22:701-8.
16. Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M, et al. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci 2011;102:1424-31.
17. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24.
18. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007;356:2271-81.
19. Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, Mori T, et al. HS DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res 2012;72:2844-54.
20. Tang D, Lotze MT. Tumor immunity times out: TIM-3 and HMGB1. Nat Immunol 2012;13:808-10.
21. Freeman GJ, Casasnovas JM, Umetsu DT, De Kruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev. 2010;235:172-89.
22. Rangachari M, Zhu C, Sakuishi K, Xiao S, Karman J, Chen A, et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat Med 2012;18:1394-400.
23. Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, Iwasaki H, et al. TIM-3 is a promising target to selectively kill acutemyeloid leukemia stem cells. Cell Stem Cell 2010;7:708-17.
24. Jan M, Chao MP, Cha AC, Alizadeh AA, Gentles AJ, Weissman IL, et al. Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proc Natl Acad Sci U S A 2011;108:5009-14.
25. Wu FH, Yuan Y, Li D, Lei Z, Song CW, Liu YY, et al. Endothelial cellexpressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-kappaB pathway. Oncol Rep 2010;24:693-9.
26. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kB as the matchmaker. Nat Immunol 2011;12:715-23.
27. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Göktuna SI, Ziegler PK, et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013;152:25-38.
28. Jinushi M, Chiba S, Yoshiyama H, Masutomi K, Kinoshita I, Dosaka-Akita H, et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci U S A 2011;108:12425-30.
29. Iliopoulos D, Hirsch HA, Wang G, Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci U S A 2011;108:1397-402.
30. Lu H, Clauser KR, Tam WL, Frose J, Ye X, Eaton EN, et al. A breast cancer stem cell niche supported by juxtacrine signaling from monocytes and macrophages. Nat Cell Biol 2014;16:1105-17.